These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36618841)

  • 21. Angiographic and Clinical Outcomes After Stent-less Coronary Intervention Using Rotational Atherectomy and Drug-Coated Balloon in Patients with De Novo Lesions.
    Shiraishi J; Kataoka E; Ozawa T; Shiraga A; Ikemura N; Matsubara Y; Nishimura T; Ito D; Kojima A; Kimura M; Kishita E; Nakagawa Y; Hyogo M; Sawada T
    Cardiovasc Revasc Med; 2020 May; 21(5):647-653. PubMed ID: 31494063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
    Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
    J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease.
    Nishiyama N; Komatsu T; Kuroyanagi T; Fujikake A; Komatsu S; Nakamura H; Yamada K; Nakahara S; Kobayashi S; Taguchi I
    Int J Cardiol; 2016 Nov; 222():113-118. PubMed ID: 27494722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Recurrent In-Stent Restenosis After Paclitaxel-Coated Balloon Angioplasty.
    Koiwaya H; Watanabe N; Kuriyama N; Nishino S; Ogata K; Kimura T; Nakama T; Matsuura H; Furugen M; Shibata Y
    Circ J; 2017 Aug; 81(9):1286-1292. PubMed ID: 28450676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial.
    Vos NS; Fagel ND; Amoroso G; Herrman JR; Patterson MS; Piers LH; van der Schaaf RJ; Slagboom T; Vink MA
    JACC Cardiovasc Interv; 2019 Sep; 12(17):1691-1699. PubMed ID: 31126887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty.
    Waksman R; Weintraub WS; Ghazzal Z; Scott NA; Shen Y; King SB; Douglas JS
    Am Heart J; 1997 Aug; 134(2 Pt 1):274-81. PubMed ID: 9313608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained Lumen Area by Paclitaxel-Coated Balloon Following Rotational Atherectomy for Napkin-Ring Left Main Trunk Ostial Lesion.
    Osawa T; Koizumi T; Ito Y
    Tex Heart Inst J; 2023 Mar; 50(2):. PubMed ID: 36947442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case Report: Directional coronary atherectomy supported with optical coherence tomography is useful for the slit lesion.
    Niizeki T; Iwayama T; Kumagai Y; Tsuchikane E
    J Cardiol Cases; 2022 Feb; 25(2):91-94. PubMed ID: 35079306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Performance of a Paclitaxel Drug-Coated Balloon in Real-World Percutaneous Coronary Intervention Practice: The PEARL Registry.
    Vlieger S; Cheng JM; Oemrawsingh RM; Weevers APJD; Polad J; Gho B; Meuwissen M; den Heijer P; Boersma E; Ijsselmuiden AJJ
    J Invasive Cardiol; 2022 Jun; 34(6):E462-E468. PubMed ID: 35652709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment for in-stent restenosis requiring rotational atherectomy.
    Hachinohe D; Kashima Y; Hirata K; Kanno D; Kobayashi K; Kaneko U; Sugie T; Tadano Y; Watanabe T; Shitan H; Haraguchi T; Enomoto M; Sato K; Fujita T
    J Interv Cardiol; 2018 Dec; 31(6):747-754. PubMed ID: 30175429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Drug-Coated Balloons in Patients with Acute Coronary Syndromes and Vulnerable Plaque.
    Zhang YB; Liu HD; Xing JH; Chen BW; Zhao YY; Gu HP; Tao HL
    Clin Appl Thromb Hemost; 2022; 28():10760296221130063. PubMed ID: 36198017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of in-hospital and follow-up results of directional atherectomy and stenting for ostial lesions of the left anterior descending coronary artery.
    Gambhir DS; Batra R; Singh S; Sudha R; Trehen V; Arora R
    Indian Heart J; 1998; 50(1):35-9. PubMed ID: 9583284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
    Vos NS; van der Schaaf RJ; Amoroso G; Herrman JP; Patterson MS; Slagboom T; Vink MA
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1213-21. PubMed ID: 26370515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
    Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.